Details for New Drug Application (NDA): 050317
✉ Email this page to a colleague
NDA 050317 describes LINCOCIN, which is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs. It is available from one supplier. Additional details are available on the LINCOCIN profile page.
The generic ingredient in LINCOCIN is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
The generic ingredient in LINCOCIN is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
Summary for 050317
| Tradename: | LINCOCIN |
| Applicant: | Pfizer |
| Ingredient: | lincomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050317
Suppliers and Packaging for NDA: 050317
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LINCOCIN | lincomycin hydrochloride | INJECTABLE;INJECTION | 050317 | NDA | Pharmacia & Upjohn Company LLC | 0009-0104 | 0009-0104-04 | 1 VIAL in 1 CARTON (0009-0104-04) / 2 mL in 1 VIAL |
| LINCOCIN | lincomycin hydrochloride | INJECTABLE;INJECTION | 050317 | NDA | Pharmacia & Upjohn Company LLC | 0009-0107 | 0009-0107-04 | 1 VIAL in 1 CARTON (0009-0107-04) / 10 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 300MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
